| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Phillip Samayoa | CHIEF SCIENTIFIC OFFICER | 2025-10-15 | 34 | $6.71 | $228.14Sell |
| Kevin John Conway | Chief Financial Officer | 2025-10-15 | 18 | $6.71 | $120.78Sell |
| Yalonda Howze | CHIEF LEGAL OFFICER | 2025-10-15 | 99 | $6.71 | $664.29Sell |
| Geoff McDonough | PRESIDENT AND CEO | 2025-10-15 | 155 | $6.71 | $1.04kSell |
| Antoinette Paone | CHIEF OPERATING OFFICER | 2025-10-15 | 47 | $6.71 | $315.37Sell |
| Geoff McDonough | PRESIDENT AND CEO | 2025-07-15 | 1,548 | $0.43 | $659.45Sell |
| Phillip Samayoa | CHIEF SCIENTIFIC OFFICER | 2025-07-15 | 337 | $0.43 | $143.56Sell |
| Antoinette Paone | CHIEF OPERATING OFFICER | 2025-07-15 | 468 | $0.43 | $199.37Sell |
| Kevin John Conway | Chief Financial Officer | 2025-07-15 | 173 | $0.43 | $73.70Sell |
| Yalonda Howze | CHIEF LEGAL OFFICER | 2025-07-15 | 983 | $0.43 | $418.76Sell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Price T Rowe Associates Inc | 125.64% | 8,462,611 | $53.40M | Institution |
| Atlas Venture Life Science Advisors LLC | 122.92% | 8,279,484 | $52.24M | Institution |
| Atlas Venture Fund X LP | 122.91% | 8,278,876 | $52.24M | Insider |
| Zone Healthcare Holdings LLC | 56.98% | 3,837,638 | $24.22M | Insider |
| William Seybold | 56.98% | 3,837,638 | $24.22M | Insider |
| Siren LLC | 44.08% | 2,968,925 | $18.73M | Institution |
| Invus Public Equities LP | 41.78% | 2,814,191 | $17.76M | Insider |
| Renaissance Technologies LLC | 38.32% | 2,580,780 | $16.28M | Institution |
| Fmr LLC | 34.82% | 2,345,624 | $14.80M | Institution |
| Vanguard Group Inc | 34.12% | 2,298,347 | $14.50M | Institution |